Aadi Bioscience (FRA:3350) Total Assets : €102.19 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Total Assets?

Aadi Bioscience's Total Assets for the quarter that ended in Mar. 2024 was €102.19 Mil.

During the past 12 months, Aadi Bioscience's average Total Assets Growth Rate was 17.10% per year. During the past 3 years, the average Total Assets Growth Rate was 17.90% per year.

During the past 4 years, Aadi Bioscience's highest 3-Year average Total Assets Growth Rate was 17.90%. The lowest was 17.90%. And the median was 17.90%.

Total Assets is connected with ROA %. Aadi Bioscience's annualized ROA % for the quarter that ended in Mar. 2024 was -60.20%. Total Assets is also linked to Revenue through Asset Turnover. Aadi Bioscience's Asset Turnover for the quarter that ended in Mar. 2024 was 0.04.

Aadi Bioscience Total Assets Historical Data

The historical data trend for Aadi Bioscience's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Total Assets Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Assets

15.47

139.75

173.92

121.43

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial										159.39	139.58	130.86	121.43	102.19

Aadi Bioscience Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aadi Bioscience's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	96.464	+	24.968
	=	121.43

Aadi Bioscience's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	83.223	+	18.964
	=	102.19

Aadi Bioscience (FRA:3350) Total Assets Explanation

Total Assets is connected with ROA %.

Aadi Bioscience's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-67.304	/	( (121.432	+	102.187)	/ 2 )
	=	-67.304	/	111.8095
	=	-60.20 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aadi Bioscience's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	4.925	/	( (121.432	+	102.187)	/ 2 )
=	4.925	/	111.8095
=	0.04

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aadi Bioscience Total Assets Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines